Status:
UNKNOWN
Network-based Approach in Type 2 Diabetes and Its Cardiovascular Risk
Lead Sponsor:
Giuditta Benincasa
Conditions:
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Eligibility:
All Genders
50+ years
Brief Summary
PIRAMIDE study design will test the hypothesis that simultaneous interactions between DNA methylation and microRNAs may hit T2D candidate genes and predict the development of T2D-related cardiovascula...
Eligibility Criteria
Inclusion
- Exclusion Criteria:
- Clinical Diagnosis of Type 2 Diabetes. In according to current guidelines, diabetes is diagnosed by evidence of impairing fast glucose (IFG) \> 7.0 mmol/L (\>125 mg/dl), post prandial glycemia \> 11.1 mmol/L (\>200 mg/dl), and evidence of glycated hemoglobin (HbA1c) \> 6.6%. Clinical and demographic characteristics of study population will be avaiable from datasets generated by physicians.
- Clinical Diagnosis of macrovascular dysfunction.
- Exclusion Criteria:
- • Patients with known history of cancer, malignancy disorders, active infections, and chronic or immune-mediated diseases.
Exclusion
Key Trial Info
Start Date :
February 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 14 2020
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03792607
Start Date
February 14 2019
End Date
June 14 2020
Last Update
September 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Università della Campania Luigi Vanvitelli
Naples, Italy